In addition to primary cancer samples, 63 metastatic foci in the lymph node, ligament, gut, and uterine serosa derived from advanced ovarian cancers and 17 ascitic samples were also used for evaluating FBI-1 protein expression by immunohistochemistry. This evidence concerns the gene ZBTB7A and cancer.